If you are thinking about a psilocybin therapy clinical trial, you may not qualify if you have certain psychiatric histories, unstable medical conditions, pregnancy or breastfeeding, or medication factors that raise risk or make results hard to interpret. These exclusions are common across many modern protocols.
How clinical trial exclusions work
Clinical trials use inclusion and exclusion criteria to protect participants and to keep results interpretable. In psilocybin trials, criteria often focus on two practical goals.
One goal is safety during the dosing day. Psilocybin can cause temporary changes in heart rate and blood pressure and it can produce intense psychological experiences that can include fear, panic, or agitation. (MDPI)
The other goal is clarity in outcomes. Trials often need a relatively stable baseline, stable medications, and limited confounding conditions so that symptom changes can be attributed to the study protocol. (ScienceDirect)
Criteria vary by condition, dose, and setting. Still, you will see recurring exclusion categories across many listings in registries and protocol papers. (ScienceDirect)
Psychiatric histories that commonly lead to exclusion
Psychotic disorders and past psychosis
A common exclusion is a personal history of a psychotic disorder or past psychosis, even if it is remote. This appears repeatedly across trial listings and is widely discussed in safety guidance for psychedelic protocols. (ClinicalTrials.gov)
The reason is risk management. Trials aim to reduce the chance of prolonged psychotic symptoms or destabilization during or after an intense acute experience. (ScienceDirect)
Bipolar I disorder and bipolar features with higher risk
Many trials exclude people with bipolar I disorder and often exclude bipolar II disorder unless the study is specifically designed for that group. Even when a protocol allows participation, it may require stable mood over time and active outpatient care. (ClinicalTrials.gov)
The safety concern is mood destabilization during the acute session or in the weeks after. Modern trials handle this by excluding higher-risk histories or by running tightly designed studies with close monitoring in a defined bipolar sample. (PMC)
Active severe depression risk markers and recent serious suicide attempt
Many protocols exclude people with recent serious suicide attempts or high acute suicide risk. You will also see exclusions for recent psychiatric hospitalization or unstable symptoms that could worsen quickly. (smartpatients.com)
The reason is practical. Trials are not built to provide emergency psychiatric care. They are built to test a protocol with planned support. When risk is acute, researchers typically direct people toward immediate clinical care rather than research participation. (ScienceDirect)
Certain dissociative or personality presentations
Some protocols exclude certain dissociative disorders or unstable clinical presentations that can raise the chance of destabilization. The exact list varies, so the most reliable approach is to read the specific trial listing and to ask the study team how they interpret the criterion. (ScienceDirect)
Family history exclusions you may not expect
Some trials exclude participants based on family history, often first-degree relatives with psychotic disorders or bipolar I disorder. This can surprise people. It is used as a conservative approach to reduce risk in early-phase work. (ClinicalTrials.gov)
Not every study uses family history exclusions. When they do, it is usually listed clearly in the registry entry.
Medical conditions that commonly lead to exclusion
Uncontrolled hypertension and significant cardiovascular disease
Uncontrolled hypertension is a frequent exclusion. Many trial listings include blood pressure cutoffs at screening, and some mention additional cardiac screening such as ECG review. (ctv.veeva.com)
The reason is straightforward. Psilocybin can temporarily increase heart rate and blood pressure. Trials reduce risk by excluding people whose cardiovascular status makes those changes more dangerous. (MDPI)
If you have treated hypertension that is stable, some protocols may allow participation after clinical clearance. Others still exclude. Trial-to-trial variation is common here. (ctv.veeva.com)
Significant neurologic disease and seizure risk
Many trials exclude a history of seizure disorder or neurologic disease that could raise risk during acute physiologic stress. Some listings use broad language that excludes serious neurologic conditions at investigator discretion. (careacross.com)
Uncontrolled endocrine or metabolic disease
Some protocols exclude people with uncontrolled metabolic conditions, including insulin-dependent diabetes in certain listings. The reason is general medical risk management and the need for stability on the dosing day. (ClinicalTrials.gov)
Pregnancy and breastfeeding
Pregnancy and breastfeeding are commonly excluded because there is limited safety data for fetal or infant exposure in these settings. Trials typically require pregnancy testing for participants who can become pregnant and may require contraception during the study window. (Psychiatrist.com)
Substance use factors that can lead to exclusion
Trials vary a lot in how they handle substance use history. Many exclude a current moderate to severe substance use disorder within a defined period, sometimes with specific exceptions. (Hopkins Medicine)
Some addiction-focused studies have their own logic. They may allow a target substance use disorder and exclude other active substance use disorders that would complicate outcomes or raise risk. (centerwatch.com)
Even when you see a nicotine exception in a listing, there may still be quantity limits. (Hopkins Medicine)
Medication exclusions and drug interaction issues
Medication rules are a major reason people do not qualify. Some studies require tapering off certain medications before dosing. Some allow certain medications with limits. Some exclude broad classes.
Antipsychotics and mood stabilizers
Many protocols exclude current antipsychotic use. Some also exclude lithium. These medications can affect safety and can change the subjective and physiological effects of the session. (centerwatch.com)
MAO inhibitors and other interacting antidepressants
MAO inhibitors are commonly excluded. Some protocols also exclude tricyclic antidepressants and other serotonergic agents. (centerwatch.com)
The reasoning includes interaction risk and interpretability. Even when severe reactions are rare, protocols often choose conservative exclusions in early work. (PMC)
SSRIs and SNRIs
This is the area with the most variation. Many research protocols historically required discontinuation of antidepressants before dosing, often with a washout window. Newer discussions raise questions about how necessary that is across all contexts, but it still appears frequently in eligibility criteria. (SAGE Journals)
Some trials allow SSRIs or SNRIs with restrictions. Others exclude all antidepressants. The specific rule is study-specific, and you should treat the registry listing as the reference point. (centerwatch.com)
Stimulants and other psychoactive medications
Some protocols exclude stimulant medications, sedative hypnotics, or other psychoactive prescriptions that could change session risk or make it hard to attribute changes to the study. Exclusions and washout windows vary. (WithPower)
Why medication rules are so strict
Medication rules protect you and protect the data. If a medication blunts subjective effects, increases physiologic stress, or changes mood instability risk, the protocol may exclude it. If a medication change is unsafe for you, you should not change it for a trial without supervision from your own clinician. (Annals of Palliative Medicine)
Condition-specific exclusions
Some trials add exclusions tied to the condition being studied.
If a trial studies a mental health condition, it may exclude other active diagnoses that would complicate outcome measurement, such as an active severe substance use disorder or unstable anxiety presentations. (Hopkins Medicine)
If a trial studies a medical condition, it may exclude broad categories of serious disease, recent major medical events, or medications tied to that condition. (careacross.com)
Practical exclusions that are not about diagnosis
Some exclusions are logistical but still important.
- Inability to attend preparation visits, dosing day, and follow-up visits
- Lack of a safe post-session plan such as a support person for transport
- Inability to comply with restrictions on driving and work immediately after dosing
- Inability to complete study assessments or language requirements (ScienceDirect)
If you are excluded for a practical reason, it does not mean you are medically ineligible. It means the study cannot run safely or consistently under its own rules.
What to do if you are excluded
Being excluded can feel personal, but it usually reflects the study design and risk tolerance, not your worthiness.
Here are safer next steps that keep you grounded.
- Ask the study team which criterion drove the decision and if it is temporary or permanent under that protocol
- Ask if a stable change, such as controlled blood pressure over time, could make you eligible later for that same protocol (ctv.veeva.com)
- Focus on evidence-based care you can access now for your condition, especially if symptoms are acute
- If medication rules are the blocker, discuss risks of changes with your prescribing clinician before taking any step (SAGE Journals)
If you want a way to compare how different protocols handle exclusions while you are already reading eligibility rules, it can help to scan how studies are presented on the clinicals page and then cross-check details in the trial registry listing for the specific study you care about.
How to read a trial listing with less confusion
When you look at a registry listing, focus on five items.
- Psychiatric exclusions and any family history exclusions (ClinicalTrials.gov)
- Cardiovascular exclusions including blood pressure cutoffs and ECG criteria (smartpatients.com)
- Medication exclusions and washout windows (SAGE Journals)
- Substance use exclusions and time windows (centerwatch.com)
- Pregnancy and contraception requirements (Psychiatrist.com)
If you read those carefully, you can usually predict eligibility before you invest time in screening calls.
Near the end, here is where we fit. We are Rose Hill Life Sciences, a psychedelic research organization specializing in the production and research of Psilocybe cubensis, operating at the intersection of science and therapeutic integration, and we are based in Massachusetts.
